GW Pharmaceuticals - 2020 insights into a breakout year
2019 has been a landmark year and we expect momentum to accelerate as Hutchison China MediTech (HCM) continues on its path to become a global...
848 Views
Hutchison China MediTech - 2020 insights into a breakout year
2019 has been a landmark year and we expect momentum to accelerate as Hutchison China MediTech (HCM) continues on its path to become a global...
748 Views
Rolling submission initiated
GW Pharmaceuticals recently announced that a rolling NDA filing for Epidiolex in both Dravet syndrome and Lennox-Gastaut syndrome (LGS) is...
85 Views
Leaving clinical risk behind
Positive data from the two Phase III trials in Lennox-Gastaut syndrome (LGS) patients, coupled with the previously announced positive Dravet...
128 Views
No more insights